AMA, IHTSDO partner to advance interoperability, standardize medical terminology

The American Medical Association (AMA) and the International Health Terminology Standards Development Organization (IHTSDO) have partnered together to develop an international system of coding and medical terminology products.

Interoperability of health information and analytics are two crucial developments for health systems wanting full integration of codes. The partnership of AMA’s Current Procedural Terminology (CPT), the standard in medical nomenclature to report medical procedures to both public and private insurances, and IHTSDO’s SNOMED CT internationally used medical terminology marks a clear step forward in clarifying and improving uniformity in healthcare interoperability.

“We are excited about this new work,” said IHTSDO CEO Don Sweete. “This new agreement focuses on specific projects to develop products that will benefit from the granularity and sophisticated structure of SNOMED CT, and the broad utility and adoption of CPT.”

The partnership will develop tool for clinicians, hospitals and payers to organize their healthcare data using system adopted internationally and across a vast majority of systems. Promoting a wide integration of their products, sharing tools and expertise to maintain standards and improve upon the current supporting systems are the first in the check list for the partnership.

"IHTSDO and the AMA view this collaboration as an important step toward increasing the coordination and integration of our terminology products to shape a better health care system,” said AMA CEO and Executive Vice President James L. Madara, MD. “We intend to use this collaboration as a foundation to achieve our shared goals of increased responsiveness to market needs and greater innovation through improved interoperability among ours and related terminologies."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.